Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$235,601
-$183,517 QoQ
Shares Held
35,376
+3.0% QoQ
Ownership
0.417%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $133,127,069,493 across 19 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,610,002 | $32,753,011,539 | |
| 2 | JNJ |
Johnson & Johnson
|
133,476,288 | $32,626,943,838 | |
| 3 | ABBV |
AbbVie Inc.
|
81,217,516 | $17,663,997,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
119,325,673 | $14,353,685,205 | |
| 5 | AMGN |
Amgen Inc
|
30,548,488 | $10,748,485,502 | |
| 6 | PFE |
Pfizer Inc
|
301,589,865 | $8,468,643,409 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
59,858,585 | $8,342,490,991 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
98,564,914 | $5,977,962,034 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $235,601 | 35,376 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $419,118 | 34,354 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $657,958 | 33,433 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $70,020 | 11,888 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||